These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25722052)

  • 21. CRISPR-Cas system: a powerful tool for genome engineering.
    Liu L; Fan XD
    Plant Mol Biol; 2014 Jun; 85(3):209-18. PubMed ID: 24639266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgene-free genome editing in Caenorhabditis elegans using CRISPR-Cas.
    Chiu H; Schwartz HT; Antoshechkin I; Sternberg PW
    Genetics; 2013 Nov; 195(3):1167-71. PubMed ID: 23979577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Noncoding RNA Domains to Genomic Loci with CRISPR-Display: Guidelines for Designing, Building, and Testing sgRNA-ncRNA Expression Constructs.
    Shechner DM
    Methods Mol Biol; 2021; 2162():115-152. PubMed ID: 32926381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruptive non-disruptive applications of CRISPR/Cas9.
    Schmid-Burgk JL
    Curr Opin Biotechnol; 2017 Dec; 48():203-209. PubMed ID: 28633080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new CRISPR-Cas system: RNA-guided genome engineering to efficiently produce any desired genetic alteration in animals.
    Seruggia D; Montoliu L
    Transgenic Res; 2014 Oct; 23(5):707-16. PubMed ID: 25092533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
    Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
    RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generating Mouse Models Using CRISPR-Cas9-Mediated Genome Editing.
    Qin W; Kutny PM; Maser RS; Dion SL; Lamont JD; Zhang Y; Perry GA; Wang H
    Curr Protoc Mouse Biol; 2016 Mar; 6(1):39-66. PubMed ID: 26928663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-guided genome editing à la carte.
    Horvath P; Barrangou R
    Cell Res; 2013 Jun; 23(6):733-4. PubMed ID: 23478298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome engineering via TALENs and CRISPR/Cas9 systems: challenges and perspectives.
    Mahfouz MM; Piatek A; Stewart CN
    Plant Biotechnol J; 2014 Oct; 12(8):1006-14. PubMed ID: 25250853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR based development of RNA editing and the diagnostic platform.
    Satish L; Lavanya G; Kasthuri T; Kalaivaani A; Shamili S; Muthuramalingam P; Gowrishankar S; Pandian SK; Singh V; Sitrit Y; Kushmaro A
    Prog Mol Biol Transl Sci; 2021; 179():117-159. PubMed ID: 33785175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR germline engineering--the community speaks.
    Bosley KS; Botchan M; Bredenoord AL; Carroll D; Charo RA; Charpentier E; Cohen R; Corn J; Doudna J; Feng G; Greely HT; Isasi R; Ji W; Kim JS; Knoppers B; Lanphier E; Li J; Lovell-Badge R; Martin GS; Moreno J; Naldini L; Pera M; Perry AC; Venter JC; Zhang F; Zhou Q
    Nat Biotechnol; 2015 May; 33(5):478-86. PubMed ID: 25965754
    [No Abstract]   [Full Text] [Related]  

  • 34. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome editing in plants using CRISPR type I-D nuclease.
    Osakabe K; Wada N; Miyaji T; Murakami E; Marui K; Ueta R; Hashimoto R; Abe-Hara C; Kong B; Yano K; Osakabe Y
    Commun Biol; 2020 Nov; 3(1):648. PubMed ID: 33159140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
    Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
    Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cas9 gRNA engineering for genome editing, activation and repression.
    Kiani S; Chavez A; Tuttle M; Hall RN; Chari R; Ter-Ovanesyan D; Qian J; Pruitt BW; Beal J; Vora S; Buchthal J; Kowal EJ; Ebrahimkhani MR; Collins JJ; Weiss R; Church G
    Nat Methods; 2015 Nov; 12(11):1051-4. PubMed ID: 26344044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating Cas9 activity for precision gene editing.
    Uslu M; Siyah P; Harvey AJ; Kocabaş F
    Prog Mol Biol Transl Sci; 2021; 181():89-127. PubMed ID: 34127203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.